Case number 2019-1770
Amgen Inc. v. Watson Laboratories, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 11 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [706233-2] filed by Appellees Watson Laboratories, Inc., Actavis Pharma, Inc. and Appellant Amgen Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [706350] [19-1650, 19-1770] [JAB] [Entered: 07/09/2020 12:18 PM] (2) |
| Jul 8, 2020 | 9 | MOTION of Appellees Actavis Pharma, Inc., Watson Laboratories, Inc. and Appellant Amgen Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 07/08/2020 by email. [706234] [19-1770] This document is non-compliant. See Doc. No. [706240-1]. [Bradford Badke] [Entered: 07/08/2020 09:01 PM] (7) |
| Apr 30, 2019 | 8 | NOTICE OF NON-COMPLIANCE: The submissions of Appellant Amgen Inc., Docketing Statement, Entries of Appearance - A. Russo, J. Murnane, J. Rothman [4], [5], [6], [7], are not in compliance with the rules of this court (see attached). Compliant documents are due in 19-1650 by 05/07/2019. Service as of this date by the Clerk of Court.[603853] [JAL] [Entered: 04/30/2019 08:46 AM] (2) |
| Apr 29, 2019 | 2 | ORDER filed. The stay of Appeal No. 19-1650 is lifted, and it and Appeal No. 2019-1770 are consolidated. One set of briefs should be filed for the two appeals. Amgen’s opening brief is due no later than 60 days from the date of filing of this order. Service: 04/29/2019 by clerk. [603597] [19-1650, 19-1770] [NL] [Entered: 04/29/2019 12:39 PM] (2) |
| Apr 29, 2019 | 3 | Note to file: The following cases are associated: 19-1650 Lead with 19-1770 Member Case. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [603618] [19-1650, 19-1770] [JAL] [Entered: 04/29/2019 01:49 PM] (0) |
| Apr 29, 2019 | 4 | Docketing Statement for the Appellant Amgen Inc.. Service: 04/29/2019 by email. [603782] [19-1770] This document is non-compliant. See Doc No.[8] [Bradford Badke] [Entered: 04/29/2019 04:46 PM] (3) |
| Apr 29, 2019 | 5 | Entry of appearance for Alicia A. Russo as of counsel for Appellant Amgen Inc.. Service: 04/29/2019 by email. [603785] [19-1770] This document is non-compliant. See Doc No.[8] [Bradford Badke] [Entered: 04/29/2019 04:48 PM] (2) |
| Apr 29, 2019 | 6 | Entry of appearance for John D. Murnane as of counsel for Appellant Amgen Inc.. Service: 04/29/2019 by email. [603787] [19-1770] This document is non-compliant. See Doc No.[8] [Bradford Badke] [Entered: 04/29/2019 04:49 PM] (2) |
| Apr 29, 2019 | 7 | Entry of appearance for Joshua I. Rothman as of counsel for Appellant Amgen Inc.. Service: 04/29/2019 by email. [603788] [19-1770] This document is non-compliant. See Doc No.[8] [Bradford Badke] [Entered: 04/29/2019 04:50 PM] (2) |
| Apr 15, 2019 | 1 | Appeal docketed. Received: 04/10/2019. [600160]Entry of Appearance is due 04/29/2019. Certificate of Interest is due on 04/29/2019. Docketing Statement is due 04/29/2019. Appellant's brief is due 06/14/2019. [JAL] [Entered: 04/15/2019 02:16 PM] (64) |
